Standard / Gradual Approach A commonly circulated convention borrows a loading then maintenance pattern from other repair peptides: a higher first phase (often cited near 500 mcg of each peptide) for several weeks, then a lower maintenance phase (near 250 mcg of each)
Engaging in further research, discussions, and explorations regarding BPC-157 could pave the way for new therapeutic strategies and applications
Its administration after spinal cord injuries has been associated with improved neuronal recovery and better motor function, highlighting its potential as a therapeutic agent in neurorehabilitation
Digital copies are also available through our COA library or by request
The WADA Prohibited List is revised on an annual basis, with each update published in October and taking effect January 1 of the following year
BPC-157s unique stability allows it to remain intact in human gastric juice for over 24 hours, distinguishing it from typical peptides that rapidly degrade
